D
DiaMedica Therapeutics Inc. DMAC
$3.75 -$0.10-2.60% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -3.27% -6.53% 2.04% 7.39% 27.93%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 35.36% 25.46% 24.33% 28.92% 34.41%
Operating Income -35.36% -25.46% -24.33% -28.92% -34.41%
Income Before Tax -40.35% -26.25% -20.73% -20.13% -24.69%
Income Tax Expenses -32.56% -30.23% 53.57% 53.57% 53.57%
Earnings from Continuing Operations -40.19% -26.12% -20.78% -20.19% -24.74%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -40.19% -26.12% -20.78% -20.19% -24.74%
EBIT -35.36% -25.46% -24.33% -28.92% -34.41%
EBITDA -35.36% -25.45% -24.32% -28.92% -34.44%
EPS Basic -16.74% 2.46% 11.25% 15.63% 5.26%
Normalized Basic EPS -16.81% 2.42% 11.32% 15.67% 5.27%
EPS Diluted -16.74% 2.46% 11.25% 15.63% 5.26%
Normalized Diluted EPS -16.81% 2.42% 11.32% 15.67% 5.27%
Average Basic Shares Outstanding 17.87% 24.56% 32.70% 42.52% 33.52%
Average Diluted Shares Outstanding 17.87% 24.56% 32.70% 42.52% 33.52%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --